BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2
35 results:

  • 1. Pan-cancer tRNA-derived fragment CAT1 coordinates RBPMS to stabilize notch2 mRNA to promote tumorigenesis.
    Yu M; Yi J; Qiu Q; Yao D; Li J; Yang J; Mi C; Zhou L; Lu B; Lu W; Ying K; Chen W; Chen E; Zhang H; Lu Z; Lu Y; Liu P
    Cell Rep; 2023 Nov; 42(11):113408. PubMed ID: 37943661
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical significance of Notch pathway-associated microRNA-107 in pancreatic ductal adenocarcinoma.
    Rashid S; Rashid S; Das P; Singh N; Dash NR; Nayak B; Sati HC; Chauhan SS; Gupta S; Saraya A
    Future Oncol; 2023 May; 19(14):1003-1012. PubMed ID: 37199277
    [No Abstract]    [Full Text] [Related]  

  • 3. Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results.
    Mauro MJ; Hughes TP; Kim DW; Rea D; Cortes JE; Hochhaus A; Sasaki K; Breccia M; Talpaz M; Ottmann O; Minami H; Goh YT; DeAngelo DJ; Heinrich MC; Gómez-García de Soria V; le Coutre P; Mahon FX; Janssen JJWM; Deininger M; Shanmuganathan N; Geyer MB; Cacciatore S; Polydoros F; Agrawal N; Hoch M; Lang F
    Leukemia; 2023 May; 37(5):1048-1059. PubMed ID: 36949155
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced notch2 inhibition.
    Huang G; Cai G; Hu D; Li J; Xu Q; Chen Z; Xu B
    Cell Oncol (Dordr); 2022 Dec; 45(6):1329-1346. PubMed ID: 36214997
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long Non-Coding RNA LINC00052 Targets miR-548p/notch2/Pyk2 to Modulate Tumor Budding and Metastasis of Human Breast cancer.
    Huang X; Yu J; Lai S; Li Z; Qu F; Fu X; Li Q; Zhong X; Zhang D; Li H
    Biochem Genet; 2023 Feb; 61(1):336-353. PubMed ID: 35918619
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preoperative biliary drainage in severely jaundiced patients with pancreatic head cancer: A retrospective cohort study.
    van Gils L; Verbeek R; Wellerdieck N; Bollen T; van Leeuwen M; Schwartz M; Vleggaar F; Molenaar IQQ; van Santvoort H; van Hooft J; Verdonk R; Weusten B;
    HPB (Oxford); 2022 Nov; 24(11):1888-1897. PubMed ID: 35803831
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids.
    Choi JI; Rim JH; Jang SI; Park JS; Park H; Cho JH; Lim JB
    Theranostics; 2022; 12(9):4431-4445. PubMed ID: 35673567
    [No Abstract]    [Full Text] [Related]  

  • 8. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
    Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
    Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Precision medicine for human cancers with Notch signaling dysregulation (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the notch2 signaling.
    Guan C; He L; Chang Z; Gu X; Liang J; Liu R
    Oncogene; 2020 Feb; 39(8):1665-1680. PubMed ID: 31659254
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of Endocrine and Exocrine Insufficiency on Quality of Life After Total Pancreatectomy.
    Stoop TF; Ateeb Z; Ghorbani P; Scholten L; Arnelo U; Besselink MG; Del Chiaro M
    Ann Surg Oncol; 2020 Feb; 27(2):587-596. PubMed ID: 31562603
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.
    Hu ZI; Bendell JC; Bullock A; LoConte NK; Hatoum H; Ritch P; Hool H; Leach JW; Sanchez J; Sohal DPS; Strickler J; Patel R; Wang-Gillam A; Firdaus I; Yu KH; Kapoun AM; Holmgren E; Zhou L; Dupont J; Picozzi V; Sahai V; O'Reilly EM
    Cancer Med; 2019 Sep; 8(11):5148-5157. PubMed ID: 31347292
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus: A Report from the Childhood cancer Survivor Study.
    Friedman DN; Moskowitz CS; Hilden P; Howell RM; Weathers RE; Smith SA; Wolden SL; Tonorezos ES; Mostoufi-Moab S; Chow EJ; Meacham LR; Chou JF; Whitton JA; Leisenring WM; Robison LL; Armstrong GT; Oeffinger KC; Sklar CA
    J Natl Cancer Inst; 2020 May; 112(5):525-532. PubMed ID: 31329225
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
    Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
    J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Notch-Induced Myeloid Reprogramming in Spontaneous pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting.
    Cheung PF; Neff F; Neander C; Bazarna A; Savvatakis K; Liffers ST; Althoff K; Lee CL; Moding EJ; Kirsch DG; Saur D; Bazhin AV; Trajkovic-Arsic M; Heikenwalder MF; Siveke JT
    Cancer Res; 2018 Sep; 78(17):4997-5010. PubMed ID: 29844119
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.
    Capodanno Y; Buishand FO; Pang LY; Kirpensteijn J; Mol JA; Argyle DJ
    Endocr Relat Cancer; 2018 Feb; 25(2):131-144. PubMed ID: 29175872
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.
    Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Konishi H; Shiozaki A; Morimura R; Ikoma H; Ochiai T; Okamoto K; Taniguchi H; Otsuji E
    Sci Rep; 2017 Jul; 7(1):5708. PubMed ID: 28720759
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immune Cytolytic Activity Stratifies Molecular Subsets of Human pancreatic cancer.
    Balli D; Rech AJ; Stanger BZ; Vonderheide RH
    Clin Cancer Res; 2017 Jun; 23(12):3129-3138. PubMed ID: 28007776
    [No Abstract]    [Full Text] [Related]  

  • 20. The Clinical Significance of miR-34a in pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.
    Long LM; Zhan JK; Wang HQ; Li S; Chen YY; Liu YS
    Pathobiology; 2017; 84(1):38-48. PubMed ID: 27458977
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.